Mississippi 2026 Regular Session

Mississippi House Bill HB1673

Introduced
1/19/26  
Refer
1/19/26  

Caption

Mississippi Pharmacy Practice Act; bring forward provision relating to nonresident pharmacies.

Impact

This bill is significant as it strengthens the oversight of nonresident pharmacies, which are those located outside Mississippi but providing pharmaceutical services to its residents. By mandating that these pharmacies maintain up-to-date licenses, submit to inspections, and adhere to local laws, the bill aims to enhance drug safety and compliance. Furthermore, pharmacies will be required to provide toll-free communication services to facilitate patient-pharmacist interactions, thus improving accessibility for consumers seeking prescription information.

Summary

House Bill 1673 aims to amend and standardize the regulations concerning nonresident pharmacies operating in the state of Mississippi. The bill brings forward Section 73-21-106 of the Mississippi Code of 1972, which pertains to nonresident pharmacies, ensuring that any out-of-state pharmacy providing services to Mississippi residents complies with state regulations. The legislation establishes requirements for these pharmacies to obtain and maintain permits, thereby ensuring the safe dispensing of prescription drugs and controlled substances within the state.

Conclusion

Overall, HB 1673 represents a step toward ensuring higher standards for pharmacies servicing Mississippi residents from out of state. By emphasizing strict compliance with both state and federal pharmacy laws, this legislation aims to protect consumers from unsafe practices while balancing the operational needs of pharmacies that serve patients across state lines.

Contention

However, there may be points of contention surrounding the implementation of these regulations, particularly regarding the potential administrative burden placed on out-of-state pharmacies and the perceived restriction on their ability to operate freely. Some stakeholders may argue that these requirements could limit patient access to medications and increase costs for nonresident pharmacies, which could ultimately be passed onto consumers. There may also be concerns regarding the enforcement capabilities of the state board to monitor compliance effectively.

Companion Bills

No companion bills found.

Previously Filed As

MS HB1288

Ivermectin; authorize pharmacists to provide to adults pursuant to collaborative pharmacy practice agreement.

MS SB2678

Pharmacy Benefit Prompt Pay Act; bring forward and prohibit spread pricing.

MS HB1612

DUI provisions; bring forward all.

MS SB2694

MS Pharmacy Practice Act; extend repealer on.

MS HB955

MS Pharmacy Practice Act; extend repealer on.

MS HB856

Pharmacy Practice Act; extend repealer on and make various changes to.

MS SB2593

Mississippi Charter Schools Act of 2013; bring forward.

MS SB2795

Pharmacy Practice Act; extend repealer on and make various changes in.

MS SB2288

Mississippi Prison Industries Act of 1990; bring forward.

MS HB252

Pharmacists; authorize to test for and administer treatment for minor, nonchronic health conditions.

Similar Bills

CA AB1503

Pharmacy.

CO HB1262

Patient Access to Compounded Medical Items

DE SB180

An Act To Amend Chapter 25, Title 24 Of The Delaware Code Relating To The Board Of Pharmacy.

CT HB06855

An Act Concerning The Department Of Consumer Protection's Recommendations Regarding Drug Control And Cannabis And Hemp Regulation.

MS HB13

Prescription drugs; authorize to be imported into the State of Mississippi.

MS HB18

Prescription drugs; authorize to be imported into the State of Mississippi.

NE LB1062

Change provisions relating to the Insurance Producers Licensing Act and the Pharmacy Benefit Manager Licensure and Regulation Act

CT HB05225

An Act Prohibiting Certain Licensees And Registrants From Selling, Dispensing, Transferring Or Delivering Any Drug Or Device To Execute A Court-imposed Sentence Of Death.